169 related articles for article (PubMed ID: 27028260)
1. Synthesis of some novel 2-substituted benzothiazole derivatives containing benzylamine moiety as monoamine oxidase inhibitory agents.
Kaya B; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1654-61. PubMed ID: 27028260
[TBL] [Abstract][Full Text] [Related]
2. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.
Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H
ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of New Thiosemicarbazone Derivative Schiff Bases as Monoamine Oxidase Inhibitory Agents.
Çavuşoğlu BK; Sağlık BN; Osmaniye D; Levent S; Acar Çevik U; Karaduman AB; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Dec; 23(1):. PubMed ID: 29283399
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors.
Ilgın S; Osmaniye D; Levent S; Sağlık BN; Acar Çevik U; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Dec; 22(12):. PubMed ID: 29232838
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, monoamine oxidase inhibition and docking studies of new dithiocarbamate derivatives bearing benzylamine moiety.
Kaya Çavuşoğlu B; Sağlık BN; Özkay Y; İnci B; Kaplancıklı ZA
Bioorg Chem; 2018 Feb; 76():177-187. PubMed ID: 29175589
[TBL] [Abstract][Full Text] [Related]
6. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.
Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816
[TBL] [Abstract][Full Text] [Related]
7. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety.
Ke S; Li Z; Qian X
Bioorg Med Chem; 2008 Aug; 16(16):7565-72. PubMed ID: 18678501
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Evaluation of 2-Amino-6-nitrobenzothiazole-Derived Hydrazones as MAO Inhibitors: Role of the Methylene Spacer Group.
Tripathi RK; Ayyannan SR
ChemMedChem; 2016 Jul; 11(14):1551-67. PubMed ID: 27332045
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase.
Zhou S; Chen G; Huang G
Bioorg Med Chem; 2018 Sep; 26(17):4863-4870. PubMed ID: 30143367
[TBL] [Abstract][Full Text] [Related]
10. Synthesis,
Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Atlı Eklioğlu Ö; Özkay Y; Koparal AS; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1422-1432. PubMed ID: 32602377
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors.
Abdelhafez OM; Amin KM; Ali HI; Abdalla MM; Batran RZ
J Med Chem; 2012 Dec; 55(23):10424-36. PubMed ID: 23153282
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
Tripathi RK; Goshain O; Ayyannan SR
ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
14. 2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B.
Takao K; Saito T; Chikuda D; Sugita Y
Chem Pharm Bull (Tokyo); 2016; 64(10):1499-1504. PubMed ID: 27725503
[TBL] [Abstract][Full Text] [Related]
15. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
[TBL] [Abstract][Full Text] [Related]
16. Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
Bonaiuto E; Milelli A; Cozza G; Tumiatti V; Marchetti C; Agostinelli E; Fimognari C; Hrelia P; Minarini A; Di Paolo ML
Eur J Med Chem; 2013; 70():88-101. PubMed ID: 24140951
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones.
Nayak BV; Ciftci-Yabanoglu S; Bhakat S; Timiri AK; Sinha BN; Ucar G; Soliman ME; Jayaprakash V
Bioorg Chem; 2015 Feb; 58():72-80. PubMed ID: 25506816
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of quinazoline amino acid derivatives as mono amine oxidase (MAO) inhibitors.
Khattab SN; Haiba NS; Asal AM; Bekhit AA; Amer A; Abdel-Rahman HM; El-Faham A
Bioorg Med Chem; 2015 Jul; 23(13):3574-85. PubMed ID: 25922182
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors.
Sağlık BN; Cebeci O; Acar Çevik U; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Sep; 25(18):. PubMed ID: 32971892
[TBL] [Abstract][Full Text] [Related]
20. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
